Renal Transplant
📧 Sign up to get email alerts when something new happens for Renal Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™ [Phase 4]
Phase 4 clinical trial evaluating cognitive outcomes in stable renal transplant patients who switched from tacrolimus to Envarsus XR.
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™ [Phase 4]
Phase 4 clinical trial update evaluating cognitive outcomes in stable renal transplant patients switched from tacrolimus to Envarsus XR.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: A Study of the Correlation Between Donor UDP-Glc and Transplanted Kidney Function
This completed clinical trial investigated whether donor UDP-glucose levels correlate with transplanted kidney function after renal transpla…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Envarsus XR® in Adolescent Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial update for Envarsus XR in adolescent kidney transplant recipients (active not recruiting).
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies [Phase 4]
Phase 4 trial update comparing IVIG/Rituximab versus Rituximab in kidney transplant patients with de novo donor-specific antibodies has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients [Phase 4]
Phase 4 trial investigating pharmacogenomic-guided tacrolimus dosing and monitoring in kidney transplant recipients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Robotic Single Port Donor Nephrectomy [NA]
Completed clinical trial on robotic single-port donor nephrectomy for left kidney donation; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery [Phase 4]
Phase 4 trial comparing deep versus moderate muscle relaxation during laparoscopic donor nephrectomy to enhance postoperative recovery.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study. [Phase 2]
Phase 2 pilot prospective study evaluating belatacept (Nulojix) in renal transplant recipients with mild immunologic risk factors, including…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) [Phase 3]
Phase 3 trial updating the efficacy and safety comparison between a calcineurin inhibitor (CNI) and a CNI-free regimen in renal transplantat…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms [Phase 4]
Phase 4 clinical trial assessing patient-reported outcomes in Korean renal transplant patients with and without gastrointestinal symptoms; t…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients [Phase 3]
A Phase 3 trial comparing enteric-coated mycophenolate sodium to mycophenolate mofetil in adult de novo renal transplant patients, with the …
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation [Phase 3]
Phase 3 trial evaluating everolimus-based immunosuppressive regimens to minimize calcineurin inhibitors in older kidney transplant recipient…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Calcineurin Inhibitor Based Immunosuppression Withdrawal [NA]
A pediatric renal transplant trial evaluating withdrawal of calcineurin inhibitor–based immunosuppression has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TOL101 induction versus anti-thymocyte globulin to prevent kidney transplant rejection, assessing safe…
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation [Phase 4]
Phase 4 trial update examining whether enteric-coated mycophenolate sodium improves quality of life in kidney transplant patients with GI sy…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Study Evaluating Rapamune® Maintenance Regimen [Phase 3]
Phase 3 study evaluating a Rapamune maintenance regimen in renal transplant recipients completed, with results posted in 2010.